Patrick Concannon

Dr. Patrick Concannon

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JBJeffrey C Barrett
Jeffrey C Barrett
DCDavid G Clayton
David G Clayton
PCPatrick Concannon
Patrick Concannon
BABeena Akolkar
Beena Akolkar
JCJason D Cooper
Jason D Cooper
SRStephen S Rich
Stephen S Rich
Patrick Concannon and colleagues present a type 1 diabetes genome-wide association study and meta-analysis in 7,514 cases and 9,045 reference samples, reporting 22 newly identified loci. Type 1 diabetes (T1D) is a common autoimmune disorder that arises from the action of multiple genetic and environmental risk factors. We report the findings of a genome-wide association study of T1D, combined in a meta-analysis with two previously published studies. The total sample set included 7,514 cases and 9,045 reference samples. Forty-one distinct genomic locations provided evidence for association with T1D in the meta-analysis (P < 10−6). After excluding previously reported associations, we further tested 27 regions in an independent set of 4,267 cases, 4,463 controls and 2,319 affected sib-pair (ASP) families. Of these, 18 regions were replicated (P < 0.01; overall P < 5 × 10−8) and 4 additional regions provided nominal evidence of replication (P < 0.05). The many new candidate genes suggested by these results include IL10, IL19, IL20, GLIS3, CD69 and IL27.

1 October 2000 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YHY Horikawa
Y Horikawa
NON Oda
N Oda
NCN J Cox
N J Cox
XLX Li
X Li
MOM Orho-Melander
M Orho-Melander
GBG I Bell
G I Bell

1 February 2013 in Science
Verified
Journal Article
Open access
PDF file
MSMichelle I. Smith
Michelle I. Smith
TYTanya Yatsunenko
Tanya Yatsunenko
MMMark Manary
Mark Manary
ITIndi Trehan
Indi Trehan
RMRajhab Mkakosya
Rajhab Mkakosya
JGJeffrey I. Gordon
Jeffrey I. Gordon
Not Just Wasting: Malnutrition is well known in Malawi, including a severe form—kwashiorkor—in which children do not simply waste away, they also suffer edema, liver damage, skin ulceration, and anorexia. Smith et al. (p. 548 ; see the Perspective by Relman ) investigated the microbiota of pairs of twins in Malawian villages and found notable differences in the composition of the gut microbiota in children with kwashiorkor. In these children, a bacterial species related to Desulfovibrio , which has been associated with bowel disease and inflammation, was noticeable. When the fecal flora from either the healthy or the sick twin was transplanted into groups of germ-free mice, the mice that received the kwashiorkor sample started to lose weight, like their human counterpart.

1 May 1998 in Cell
Verified
Journal Article
Closed access
RVRaymonda Varon
Raymonda Varon
CVChristine Vissinga
Christine Vissinga
MPMatthias Platzer
Matthias Platzer
KCKaren M Cerosaletti
Karen M Cerosaletti
KCKrystyna Chrzanowska
Krystyna Chrzanowska
ARAndré Reis
André Reis

7 August 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
AAAntonis C. Antoniou
Antonis C. Antoniou
SCSilvia Casadei
Silvia Casadei
THTuomas Heikkinen
Tuomas Heikkinen
DBDaniel Barrowdale
Daniel Barrowdale
KPKatri Pylkäs
Katri Pylkäs
MTMarc Tischkowitz
Marc Tischkowitz
To the Editor: We read the article by Antoniou et al. (August 7 issue)1 because we like to know the penetrance of breast-cancer genes before we recommend surgery. After reading the article, we are unsure of what to tell patients. The simplest message would be that the risk up to 70 years of age is 35%, but this is based on an analysis of patients who received a diagnosis of breast cancer from 1930 to the present. The relevant risk value is that for a woman without breast cancer who is found to have a PALB2 mutation today. Most patients . . .

1 April 2008 in Diabetes
Verified
Journal Article
Closed access
PDF file
HEHenry Erlich
Henry Erlich
Ana M ValdesAna M Valdes
Ana M Valdes
JNJanelle Noble
Janelle Noble
JCJoyce A. Carlson
Joyce A. Carlson
MVMike Varney
Mike Varney
PMPriscilla Moonsamy
Priscilla Moonsamy
OBJECTIVE—The Type 1 Diabetes Genetics Consortium has collected type 1 diabetic families worldwide for genetic analysis. The major genetic determinants of type 1 diabetes are alleles at the HLA-DRB1 and DQB1 loci, with both susceptible and protective DR-DQ haplotypes present in all human populations. The aim of this study is to estimate the risk conferred by specific DR-DQ haplotypes and genotypes. RESEARCH DESIGN AND METHODS:—Six hundred and seven Caucasian families and 38 Asian families were typed at high resolution for the DRB1, DQA1, and DQB1 loci. The association analysis was performed by comparing the frequency of DR-DQ haplotypes among the chromosomes transmitted to an affected child with the frequency of chromosomes not transmitted to any affected child. RESULTS—A number of susceptible, neutral, and protective DR-DQ haplotypes have been identified, and a statistically significant hierarchy of type 1 diabetes risk has been established. The most susceptible haplotypes are the DRB1*0301-DQA1*0501-DQB1*0201 (odds ratio [OR] 3.64) and the DRB1*0405-DQA1*0301-DQB1*0302, DRB1*0401-DQA1*0301-DQB*0302, and DRB1*0402-DQA1*0301-DQB1*0302 haplotypes (ORs 11.37, 8.39, and 3.63), followed by the DRB1*0404-DQA1*0301-DQB1*0302 (OR 1.59) and the DRB1*0801-DQB1*0401-DQB1*0402 (OR 1.25) haplotypes. The most protective haplotypes are DRB1*1501-DQA1*0102-DQB1*0602 (OR 0.03), DRB1*1401-DQA1*0101-DQB1*0503 (OR 0.02), and DRB1*0701-DQA1*0201-DQB1*0303 (OR 0.02). CONCLUSIONS—Specific combinations of alleles at the DRB1, DQA1, and DQB1 loci determine the extent of haplotypic risk. The comparison of closely related DR-DQ haplotype pairs with different type 1 diabetes risks allowed identification of specific amino acid positions critical in determining disease susceptibility. These data also indicate that the risk associated with specific HLA haplotypes can be influenced by the genotype context and that the trans-complementing heterodimer encoded by DQA1*0501 and DQB1*0302 confers very high risk.